Company Search:
Advanced Search
Sponsored Links
MDxHealth S.A. Company Snapshot
MDxHealth S.A. operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares MDxHealth S.A. with three other companies in this sector in Belgium: Tigenix Nv (2016 sales of 25.40 million Euro [US$31.12 million] of which 100% was Pharmaceuticals), Thrombogenics Nv (7.10 million Euro [US$8.71 million] of which 100% was Royalty Income), and argenx NV (14.71 million Euro [US$18.03 million] of which 62% was License Fees).

Sales Analysis. MDxHealth S.A. reported sales of 27.15 million Euro (US$33.28 million) for the year ending December of 2016. This represents an increase of 69.8% versus 2015, when the company's sales were 15.99 million Euro. Sales at MDxHealth S.A. have increased during each of the previous five years (and since 2011, sales have increased a total of 1,377%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
MDxHealth S.A.
  Stock Performance Chart for MDxHealth S.A.
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 3.53
(Figures in Euro)
1 Week 9.6%   13 Weeks -4.4%  
4 Weeks -23.8%   52 Weeks -26.8%  
MDxHealth S.A. Key Data:
  Ticker: MDXH Country: Belgium
  Exchanges: BRU Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 27,153,419
(Year Ending Jan 2017).
Employees: 162
  Currency: Euro Market Cap: 176,321,410
  Fiscal Yr Ends: December Shares Outstanding: 49,949,408
  Share Type: Action Ordinaries Closely Held Shares: 6,609,526
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.